New Insights into the Genetic Architecture of Attention Deficit Hyperactivity Disorder (ADHD)

A comprehensive study on the genetics of Attention Deficit Hyperactivity Disorder (ADHD) has shed new light on the condition's complex genetic architecture. Researchers at Boston Children's Hospital have analyzed the genomes of 150 pediatric ADHD cases and 370 controls, revealing distinct genetic pathways that contribute to the development of ADHD. The study's findings suggest that rare and common genetic variants play a crucial role in the genetic etiology of ADHD, with potential implications for the development of diagnostic and therapeutic approaches.

Key Takeaways:

  • The study investigated the genetic architecture of ADHD, focusing on the role of rare and common genetic variants.
  • Genome sequencing was performed on 150 pediatric ADHD cases and 370 controls to identify genetic patterns.
  • ADHD polygenic scores were derived and compared across five methods, including two published GWAS and two publicly available catalogs.
  • Likely pathogenic rare variants were identified in 13% of cases and 0.5% of controls, with cases carrying rare variants having lower ADHD polygenic scores.
  • ADHD cases without rare variants had higher ADHD polygenic scores than cases carrying rare variants.
  • The study's predictions indicate that ancestry, rare variant status, and ADHD and IQ polygenic scores contribute significantly to the development of ADHD.

Statistics:

  • 150 pediatric ADHD cases were included in the study.
  • 370 controls were used for comparison.
  • 13% of cases carried likely pathogenic rare variants.
  • 0.5% of controls carried likely pathogenic rare variants.
  • The study's predictions indicated an area under the curve of 70% for predicting ADHD cases based on ADHD and IQ polygenic scores, ancestry, and rare variant status.

Sources:

  • Common and Rare Genetic Variants Explain Distinct Diagnostic Variance in Pediatric Attention Deficit Hyperactivity Disorder. Genetics in Medicine, 2025:101598.
  • Elsevier Science Inc, Ste 800, 230 Park Ave, New York, NY 10169, USA.
  • Nature Publishing Group - www.nature.com/.
  • Genetics in Medicine - www.nature.com/gim/.